Responses of genes involved in cell cycle control to diverse DNA damaging chemicals in human lung adenocarcinoma A549 cells

Cancer Cell International

Volumn 5, Issue , 2005, Pages

  Zhu, Huijun ^a   Smith, Catherine ^a   Ansah, Charles ^a   Gooderham, Nigel J ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

2 AMINO 1 METHYL 6 PHENYLIMIDAZO[4,5 B]PYRIDINE; ALKALOID; ANTINEOPLASTIC AGENT; BENZO[A]PYRENE; CARCINOGEN; CELL CYCLE PROTEIN; CELL DNA; COMPLEMENTARY DNA; CRYPTOLEPINE; CYCLIN D1; CYCLIN DEPENDENT KINASE 3; CYCLIN DEPENDENT KINASE INHIBITOR 1; CYTOCHROME P450 1B1; CYTOTOXIC AGENT; DIMETHYL SULFOXIDE; ETOPOSIDE; GENE PRODUCT; MESSENGER RNA; MINICHROMOSOME MAINTENANCE PROTEIN; POLYCYCLIC AROMATIC HYDROCARBON; PROTEIN ANTIBODY; PROTEIN BAX; PROTEIN MDM2; PROTEIN P21; PROTEIN P53; PROTEIN TYROSINE PHOSPHATASE; RETINOBLASTOMA PROTEIN; TRANSCRIPTION FACTOR E2F; TRANSFORMING GROWTH FACTOR BETA; UNINDEXED DRUG;

ARTICLE; CANCER CELL CULTURE; CELL CYCLE; CELL FATE; CONTROLLED STUDY; CYTOTOXICITY; DNA DAMAGE; DRUG MECHANISM; GENE EXPRESSION; GENE FUNCTION; HUMAN; HUMAN CELL; LUNG ADENOCARCINOMA; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; TUMOR SUPPRESSOR GENE;

EID: 26844548736     PISSN: 14752867     EISSN: 14752867     Source Type: Journal    
DOI: 10.1186/1475-2867-5-28     Document Type: Article

References (55)

1. Garber K: NIH launches chemical genetics initiative. J Natl Can Inst 2003, 95:1740-1741.
2. Knudsen KE, Booth D, Naderi S, Sever-Chroneos Z, Fribourg AF, Hunton IC, Feramisco JR, Wang JY, Knudsen ES: RB-dependent S-phase response to DNA damage. Mol Cell Biol 2000, 20:7751-63.
3. Kao GD, McKenna WG, Yen TJ: Detection of repair activity during the DNA damage-induced G2 delay in human cancer cells. Oncogene 2001, 20:3486-96.
4. Bonjean K, De Pauw-Gillet MC, Defresne MP, Colson P, Houssier C, Dassonneville L, Bailly C, Greimers R, Wright C, Quetin-Leclercq J, Tits M, Angenot L: The DNA intercalating alkaloid cryptolepine interferes with topoisomerase II and inhibits primarily DNA synthesis in B16 melanoma cells. Biochemistry 1998, 37:5136-46.
5. Yang SW, Abdel-Kader M, Malone S, Werkhoven MC, Wisse JH, Bursuker I, Neddermann K, Fairchild C, Raventos-Suarez C, Menendez AT, Lane K, Kingston DG: Synthesis and biological evaluation of analogues of cryptolepine, an alkaloid isolated from the Suriname rainforest. J Nat Prod 1999, 62:976-83.
6. Ansah C, Gooderham NJ: The popular herbal antimalarial, extract of Cryptolepis sanguinolenta, is potently cytotoxic. Toxicol Sci 2002, 70:245-51.
7. Smith LE, Denissenko MF, Bennett WP, Li H, Amin S, Tang M, Pfeifer GP: Targeting of Lung Cancer Mutational Hotspots by Polycyclic Aromatic Hydrocarbons. J Natl Cancer Inst 2000, 92:803-811.
8. Kadlubar FF, Badawi AF: Genetic susceptibility and carcinogen-DNA adduct formation in human urinary bladder carcinogenesis. Toxicol Lett 1995, 82-83:627-32.
9. Li D, Walcott FL, Chang P, Zhang W, Zhu J, Petrulis E, Singletary SE, Sahin AA, Bondy ML: Genetic and environmental determinants on tissue response to in vitro carcinogen exposure and risk of breast cancer. Cancer Res 2002, 62:4566-70.
10. Harvey RG: Polycyclic aromatic hydrocarbons: chemistry and carcinogenicity (Cambridge U.K.). Cambridge University Press; 1991.
11. Shimada T, Gillam EM, Oda Y, Tsumura F, Sutter TR, Guengerich FP, Inoue K: Metabolism of benzo[a]pyrene to trans-7, 8-dihydroxy-7, 8-dihydrobenzo[a]pyrene by recombinant human cytochrome P450 1B1 and purified liver epoxide hydrolase. Chem Res Toxicol 1999, 12:623-9.
12. Nebert DW, Roe AL, Dieter MZ, Solis WA, Yang Y, Dalton TP: Role of the aromatic hydrocarbon receptor and [Ah] gene battery in the oxidative stress response, cell cycle control, and apoptosis. Biochem Pharmacol 2000, 59:65-85.
13. Murray GI, Melvin WT, Greenlee WF, Burke MD: Regulation, function, and tissue-specific expression of cytochrome P450 CYP1B1. Annu Rev Pharmacol Toxicol 2001, 41:297-316.
14. Hoffman EC, Reyes H, Chu FF, Sander F, Conley LH, Brooks BA, Hankinson O: Cloning of a factor required for activity of the Ah (dioxin) receptor. Science 1991, 252:954-958.
15. Whitlock JPJ: Mechanistic aspects of dioxin action. Chem Res Toxicol 1993, 6:754-763.
16. Hankinson O: The aryl hydrocarbon receptor complex. Annu Rev Pharmacol Toxicol 1995, 35:307-340.
17. Sutter TR, Greenlee WF: Classification of members of the Ah gene battery. Chemosphere 1992, 25:223-226.
18. Wang F, Wang W, Safe S: Regulation of constitutive gene expression through interactions of Sp1 protein with the nuclear aryl hydrocarbon receptor complex. Biochemistry 1999, 38:11490-11500.
19. Marlowe JL, Knudsen ES, Schwemberger S, Puga A: The Aryl Hydrocarbon Receptor Displaces p300 from E2F-dependent Promoters and Represses S Phase-specific Gene Expression. J Biol Chem 2004, 279:29013-22.
20. Sugimura T, Sato S: Mutagens-carcinogens in foods. Cancer Res 1983, 43:2415s-2421.
21. Zhao K, Murray S, Davies DS, Boobis AR, Gooderham NJ: Metabolism of the food derived mutagen and carcinogen 2-amino-1-methyl- 6-phenylimidazo(4,5-b)pyridine (PhIP) by human liver microsomes. Carcinogenesis 1994, 15:1285-1288.
22. Crofts FG, Sutter TR, Strickland PT: Metabolism of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine by human cytochrome P4501A1, P4501A2 and P4501B1. Carcinogenesis 1998, 19:1969-1973.
23. Turesky RJ, Lang NP, Butler MA, Teitel CH, Kadlubar FF: Metabolic activation of carcinogenic heterocyclic aromatic amines by human liver and colon. Carcinogenesis 1991, 12:1839-1845.
24. Hukkanen J, Lassila A, Päivärinta K, Valanne S, Sarpo S, Hakkola J, Pelkonen O, Raunio H: Induction and regulation of xenobiotic-metabolizing cytochrome P450s in the human A549 Lung adenocarcinoma cell line. Am J Respir Cell Mol Biol 2000, 22:360-366.
25. Dohr O, Sinning R, Vogel C, Munzel P, Abel J: Effect of transforming growth factor-beta1 on expression of aryl hydrocarbon receptor and genes of Ah gene battery: clues for independent down-regulation in A549 cells. Mol Pharmacol 1997, 51:703-10.
26. Kastan MB, Zhan Q, el-Deiry WS, Carrier F, Jacks T, Walsh WV, Plunkett BS, Vogelstein B, Fornace AJ Jr: A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 Is defective In ataxia-telangiectasia. Cell 1992, 71:587-97.
27. Massagué J, Chen Y: Controlling TGF-β signalling. Genes & Dev 2000, 14:627-644.
28. Vidal A, Koff A: Cell-cycle inhibitors: three families united by a common cause. Gene 2000, 247:1-15.
29. Khan QA, Anderson LM: Hydrocarbon carcinogens evade cellular defense mechanism of G1 arrest in nontransformed and malignant lung cell lines. Toxicol Appl Pharmacol 2001, 173:105-13.
30. Kastan MB, Onyekwere O, Sidransky D, Vogelstein B, Craig RW: Participation of p53 protein in the cellular response to DNA damage. Cancer Res 1991, 51:6304-6311.
31. Nelson WG, Kastan MB: DNA strand breaks: the DNA template alterations that trigger p53-dependent DNA damage response pathways. Mol Cell Biol 1994, 14:1815-1823.
32. El-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, Lin D, Mercer WE, Kinzler KW, Vogelstein B: WAF1, a potential mediator of p53 tumor suppression. Cell 1993, 75:817-25.
33. El-Deiry WS, Harper JW, O'Connor PM, Velculescu VE, Canman CE, Jackman J, Pietenpol JA, Burrell M, Hill DE, Wang Y: WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis. Cancer Res 1994, 54:1169-1174.
34. Shivakumar CV, Brown DR, Deb S, Deb SP: Wild-type human p53 transactivates the human proliferating cell nuclear antigen promoter. Mol Cell Biol 1995, 15:6785-6793.
35. Miyashita T, Reed JC: Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell 1995, 80:293-9.
36. MacLachlan TK, Takimoto R, El-Deiry WS: BRCA1 directs a selective p53-dependent transcriptional response towards growth arrest and DNA repair targets. Mol Cell Biol 2002, 22:4280-4292.
37. Cip1 Cdk inhibitor influences the outcome of the p53 response to DNA damage. Nature 2002, 419:729-734.
38. Butt AJ, Firth SM, King MA, Baxter RC: Insulin-like growth factor-binding protein-3 modulates expression of Bax and Bcl-2 and potentiates p53-independent radiation-induced apoptosis in human breast cancer cells. J Biol Chem 2000, 275:39174-39181.
39. Fang S, Jensen JP, Ludwig RL, Vousden KH, Weissman AM: Mdm2 is a RING finger-dependent ubiquitin protein ligase for itself and p53. J Biol Chem 2000, 275:8945-8951.
40. Honda R, Yasuda H: Activity of MDM2, a ubiquitin ligase, toward p53 or itself is dependent on the RING finger domain of the ligase. Oncogene 2000, 19:1473-1476.
41. Honda R, Yasuda H: Association of p19(ARF) with Mdm2 inhibits ubiquitin ligase activity of Mdm2 for tumor suppressor p53. EMBO J 1999, 18:22-7.
42. Stott FJ, Bates S, James MC, McConnell BB, Starborg M, Brookes S, Palmero I, Ryan K, Hara E, Vousden KH, Peters G: The alternative product from the human CDKN2A locus, p14(ARF), participates in a regulatory feedback loop with p53 and MDM2. EMBO J 1998, 17:5001-14.
43. Xirodimas DP, Chisholm J, Desterro JMS, Lane DP, Hay RT: p14ARF promotes accumulation of SUMO-1 conjugated (H)Mdm2. FEBS Lett 2002, 528:207-211.
44. Buschmann T, Lerner D, Lee CG, Ronai Z: The Mdm-2 amino terminus is required for Mdm2 binding and SUMO-1 conjugation by the E2 SUMO-1 conjugating enzyme Ubc9. J Biol Chem 2001, 276:40389-95.
45. Shimada T, Martin MV, Pruess-Schwartz D, Marnett LJ, Guengerich FP: Roles of individual human cytochrome P-450 enzymes in the bioactivation of benzo(a)pyrene, 7,8-dihydroxy-7,8- dihydrobenzo(a)pyrene, and other dihydrodiol derivatives of polycyclic aromatic hydrocarbons. Cancer Res 1989, 49:6304-6312.
46. Shimada T, Hayes CL, Yamazaki H, Amin S, Hecht SS, Guengerich FP, Sutter TR: Activation of chemically diverse procarcinogens by human cytochrome P-450 1B1. Cancer Res 1996, 56:2979-2984.
47. Feldman G, Remsen J, Shinohara K, Cerutti P: Excisability and persistence of benzo(a)pyrene DNA adducts in epithelioid human lung cells. Nature 1978, 274:796-798.
48. Kang MK, Kameta A, Shin KH, Baluda MA, Kim HR, Park NH: Senescence-associated genes in normal human oral keratinocytes. Exp Cell Res 2003, 287:272-278.
49. Alexander DL, Ganem LG, Fernandez-Salguero P, Gonzalez F, Jefcoate CR: Aryl-hydrocarbon receptor is an inhibitory regulator of lipid synthesis and of commitment to adipogenesis. J Cell Sci 1998, 111:3311-3322.
50. Venugopal M, Agarwal R, Callaway A, Schut HA, Snyderwine EG: Inhibition of cell death in human mammary epithelial cells by the cooked meat-derived carcinogen 2-amino-1-methyl-6- phenylimidazo [4,5-b]pyridine. Biochem Biophys Res Commun 1999, 266:203-7.
51. Lauber SN, Ali S, Gooderham NJ: The cooked food derived carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b] pyridine is a potent oestrogen: a mechanistic basis for its tissue-specific carcinogenicity. Carcinogenesis 2004, 25:2509-17.
52. Zhu H, Gooderham NJ: Neoplastic transformation of human lung fibroblast MRC-5 SV2 cells induced by benzo[a]pyrene and confluence culture. Cancer Res 2002, 62:4605-4609.
53. Brazma A, Hingamp P, Quackenbush J, Sherlock G, Spellman P, Stoeckert C, Aach J, Ansorge W, Ball CA, Causton HC, Gaasterland T, Glenisson P, Holstege FCP, Kim FI, Markowitz V, Matese JC, Parkinson H, Robinson A, Sarkans U, Schulze-Kremer S, Stewart J, Taylor R, Vilo J, Vingron M: Minimum information about a microarray experiment (MIAME) - toward standards for microarray data. Nat Genetics 2001, 29:365-371.
54. Wodicka L, Dong H, Mittmann M, Ho M, Lockhart DJ: Genomewide expression monitoring in Saccharomyces cerevisiae. Nat Biotechnol 1997, 15:1359-1367.
55. Dahlquist KD, Salomonis N, Vranizan K, Lawlor SC, Conklin BR: GenMAPP, a new tool for viewing and analyzing microarray data on biological pathways. Nat Genetics 2002, 31:19-20.